Log in

FDA approves Kisunla (donanemab), CMH patients take part in FDA-approved drug trial

Posted 7/5/24

Alzheimer’s disease patients now have another medication option that may help slow the progression of the disease, and Citizens Memorial Hospital (CMH) patients played a role in the drug’s approval.

This item is available in full to subscribers.

Please log in to continue



X
X